Federal Court of Appeal Decisions

Decision Information

Merck & Co. Inc. v. Apotex Inc.

Court (s) Database Federal Court of Appeal Decisions
Date 2006-09-11
Neutral citation 2006 FCA 297
File numbers A-33-06

Decision Content

Date: 20060911

Docket: A-33-06

Citation: 2006 FCA 297

 

CORAM:       LINDEN J.A.

                        SEXTON J.A.

                        MALONE J.A.

 

BETWEEN:

MERCK & CO., INC., MERCK FROSST CANADA & CO.

MERCK FROSST CANADA LTD., SYNGENTA LIMITED

ASTRAZENECA UK LIMITED and ASTRAZENECA CANADA INC.

 

Appellants

and

APOTEX INC.

Respondent

 

 

 

 

Heard at Toronto, Ontario, on September 11, 2006.

Judgment delivered from the Bench at Toronto, Ontario, on September 11, 2006.

 

REASONS FOR JUDGMENT OF THE COURT BY:                                                 SEXTON J.A.

 

Date: 20060911

Docket: A-33-06

Citation: 2006 FCA 297

 

CORAM:       LINDEN J.A.

                        SEXTON J.A.

                        MALONE J.A.

 

BETWEEN:

MERCK & CO., INC., MERCK FROSST CANADA & CO.

MERCK FROSST CANADA LTD., SYNGENTA LIMITED

ASTRAZENECA UK LIMITED and ASTRAZENECA CANADA INC.

 

Appellants

and

APOTEX INC.

Respondent

 

 

 

 

REASONS FOR JUDGMENT OF THE COURT

(Delivered from the Bench at Toronto, Ontario, on September 11, 2006)

SEXTON J.A.

[1]               We see no merit in the appeal. The Trial Judge exercised his discretion to allow the amendments. He permitted the appellants to have further examinations for discovery and to lead further evidence. To the extent they wished, the appellants did this. Furthermore, the Trial Judge dealt with these issues in his Reasons for Judgment. We see no reason to interfere with the discretion of the Trial Judge.

 

[2]               The appeal will be dismissed with costs.

 

“J. Edgar Sexton” 

J.A.

FEDERAL COURT OF APPEAL

 

NAMES OF COUNSEL AND SOLICITORS OF RECORD

 

 

 

DOCKET:                                                                              A-33-06

 

(APPEAL FROM AN ORDER OF THE FEDERAL COURT DATED JANUARY 10, 2006, DOCKET NO. T-2792-96)

 

STYLE OF CAUSE:                                                              MERCK & CO., INC., MERCK FROSST CANADA & CO., MERCK FROSST CANADA LTD., SYNGENTA LIMITED, ASTRAZENECA UK LIMITED and ASTRAZENECA CANADA INC.

                                                                                                v.

                                                                                                APOTEX INC.

 

 

PLACE OF HEARING:                                                        Toronto, Ontario

 

 

DATE OF HEARING:                                                          September 11, 2006

 

 

REASONS FOR JUDGMENT OF THE COURT BY:       (LINDEN, SEXTON,

                                                                                                MALONE  JJ.A.)

 

DELIVERED FROM THE BENCH BY:                            SEXTON J.A.

 

 

APPEARANCES:

 

Judith Robinson

Patrick Kierans

Jordana Sanft

 

 

Gunars  Gaikis

Sheldon Hamilton

Nancy Pei

Denise Lacombe

 

 

FOR THE APPELLANTS

Merck & Co. Inc., Merck Frosst Canada & Co., and Merck Frosst Canada Ltd.

 

FOR THE APPELLANTS

Syngenta Limited, AstraZeneca UK Limited, and AstraZeneca Canada Inc.

 

 

 

 

 

H.B. Radomski

D.M. Scrimger

Nando De Luca

Miles Hastie

 

FOR THE RESPONDENT

 

SOLICITORS OF RECORD:

 

Ogilvy Renault

Montreal, Quebec

 

 

 

Smart & Biggar

Toronto, Ontario

 

 

 

FOR THE APPELLANTS

Merck & Co. Inc., Merck Frosst Canada & Col, and Merck Frosst Canada Ltd.

 

FOR THE APPELLANTS 

Syngenta Limited, AstraZeneca UK Limited, and AstraZeneca Canada Inc.

 

 

 

 

Goodmans

Toronto, Ontario

 

FOR THE RESPONDENT

 

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.